SI
Sigyn Therapeutics, Inc.
SIGY · OTC
$0.03 -2.79% (-$0.00)
1M +16.00%
Market Cap $57.8K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.04
14.9% upside
Trenutna cena
$0.035
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SIGY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 37.61%
ROA 7,197.69%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -3.98x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -0.06x
EPS volatility 2,404.83%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SIGY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James A. Joyce
Employees
4
Headquarters
San Diego
Prihajajoči dogodki
18 NOV.
Earnings
Upcoming earnings report